MetaCap

Beta Bionics Statistics

NASDAQ: BBNXHealth CareMedical/Dental InstrumentsUSD

17.63+0.20 (+1.15%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Beta Bionics by the numbers

Beta Bionics has a market capitalization of $951.1 million based on 53.95M shares outstanding. With trailing EPS of $-1.66, Beta Bionics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.0% below its 50-day average and 13.0% above its 200-day average.

Average daily trading volume is 1.31M shares, or about $23.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BBNX valuation vs. peer median

BBNX compared with the median of 8 peer companies
MetricBBNXPeer medianDifference
Market cap$951.07M$1.04B-9%
Avg. volume1.31M625.95K+110%

Peer median across 8 companies: BVS, SIBN, AORT, IART, PRCT, TNDM, DRTS, DCTH.

Valuation

Market cap
$951.07M
Price / sales (latest FY)
9.49
EPS (TTM)
$-1.66

Price and trading

Previous close
17.43
Open
17.47
Day range
17.13 – 17.88
52-week range
8.80 – 32.71
52-week change
-21.24%
Beta
—
Volume
955.10K

Dividends and events

Annual dividend
None
Next earnings date
Oct 27, 2026

Additional statistics

Market Cap
951.07M
Forward Pe
-7.58
Eps
-1.66
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
32.71
Week52 Low
8.80
Avg Volume
1.31M
Shares Outstanding
53.95M
Ma50
18.56
Ma200
15.60
Earnings Date
Oct 27, 2026
Pct From52w High
-46.10%
Pct From52w Low
100.34%

Related